Blog

Access to Medicines

Pharma Pricing Secrecy Runs Amok 

Funding the Fight

Congress’s Spending Bill Does Not Meet the Moment 

Access to Medicines

U.S. Torpedoes Extension of WTO TRIPS Decision to Include Tests and Treatments and Hides Behind the Façade of... 

Health Justice

PEPFAR can’t keep burying its head in the sand when it comes to Key Populations 

Funding the Fight

We’re turning up the heat on policymakers this World AIDS Day 

Our Story

Q&A with Naike Ledan, Associate Director of International Policy & Advocacy 

Access to Medicines

Switzerland and Mexico’s Communication to the TRIPS Council is Replete with Disinformation and Their Que... 

Access to Medicines

Bad Faith from Big Pharma, Rich Countries and the WTO Poison WTO TRIPS Waiver Negotiations 

Access to Medicines

Time to Walk Away from the WTO Proposed Text 

Access to Medicines

The Quad TRIPS Waiver Text is not a Compromise; It is an Abomination 

Access to Medicines

Moderna’s Global Public Health Strategy:  Parsing the Hype and Shameful Access Gaps 

Health Justice

Africa’s Key Populations Demand Bold Action, Not Empty Promises 

Access to Medicines

Merck’s Molnupiravir – Overcoming impending barriers to affordable global access 

Access to Medicines

Biggest Roadblock to Biden-Convened COVID-19 Summit’s Success: Fealty to Moderna and Pfizer 

COVID-19

The Global Fund: A Foundation for Health Equity 

SEE MORE